2009 Honda Odyssey Touring
3.5 L • V6 • 244 hp • FWD • AT
5FNRL38909B011355
Sales history: 1
• $225Highlights
Condition
Not provided
Seller
Unknown
Key included
Yes
Docs
Good
History
1 record
Drive
3.5 L • V6 • 244 hp • FWD • AT
Odometer
Not provided
Primary damage
Biohazard chemical
Secondary damage
Front end
Docs
MO • Salvage Title
Auction
VIN
5FNRL38909B011355
Lot number
69308785
Copart
Sale status
Sold
Location
St. Louis, MO
Description
Fuel type
Gasoline
Body color
Silver
Body type
Minivan
Generation
RL3
Trim
Touring
All sales final. Always run reports before bid
Sharing our own experience
Over the years, we’ve learned all the ins and outs of car importing — so you don’t have to.
How it works
A full step-by-step guide that walks you through the entire process — from signing up to receiving your car at your doorstep. Clear & beginner-friendly.
Purchase process
Knowledge base
A structured library of content covering every major topic in car importing — including terms, rules, key concepts, and important real-world nuances.
Import encyclopedia
Watch & learn
Short, practical videos packed with tips from real experience. No fluff, no theory — just what actually helps when importing a car from the US to Poland.
Watch guides
Popular Honda models
2009 Honda Odyssey Touring • 3.5 L • V6 • 244 hp • FWD • Automatic • Copart Lot: 69308785 • VIN: 5FNRL38909B011355
Find out more about this 2009 Honda Odyssey Touring, available at the Copart salvage car auction as lot #69308785 in St. Louis, MO. This car has Biohazard chemical main damage. It is listed with Not provided start condition code. Odometer shows Not provided. This Silver Honda Odyssey Minivan is equipped with Gasoline 3.5 L engine, FWD drivetrain, Automatic transmission. Check the vehicle history report for 5FNRL38909B011355 to access detailed information on accidents, ownership, and title status. Review pricing trends and uncover hidden issues before placing your bid.
We use cookies to improve your experience and analyze site usage, as outlined in our Privacy policy. By closing this message or continuing to browse, you consent to their use.
